Current Progress

Submission received

NMG meeting

AWMSG meeting

Ministerial Ratification

AWMSG advice

Raltegravir (Isentress®) is recommended as an option for use within NHS Wales for the treatment of HIV-1 infection in treatment-experienced adults in accordance with British HIV Association (BHIVA) guidance.
Raltegravir (Isentress®) is not suitable for shared care within NHS Wales.